Articles related to DIARRHEA

Linzess is the first treatment approved for IBS-C in pediatric patients. Patients younger than 2 years can be at risk of serious dehydration and should not take Linzess for any indication.

Conditions that warrant gastrointestinal pathogen panel testing include fever, visible blood in the stool, sepsis, severe abdominal pain, hospitalization, persistent diarrhea (≥ 7 days), advanced age, and immunocompromise.

High doses of loperamide, an OTC antidiarrheal, are being abused for opioid-like effects, leading to severe cardiac risks. Clinicians should screen for loperamide toxicity in patients with a history of opioid use presenting with related symptoms.

Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.

The relationship between anxiety and gut health opens up new avenues for understanding and treating anxiety diarrhea. By exploring dietary adjustments, probiotic supplements, herbal interventions, and complementary therapies, physicians may find comprehensive solutions for their patients dealing with these distressing symptoms.